CareDx, Inc. (CDNA)
64.00
-2.68
(-4.01%)
USD |
NASDAQ |
Oct 16, 16:00
63.66
-0.34
(-0.53%)
After-Hours: 20:00
CareDx Research and Development Expense (Annual) : 71.43M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 71.43M |
| December 31, 2024 | 72.40M |
| December 31, 2023 | 81.87M |
| December 31, 2022 | 90.39M |
| December 31, 2021 | 76.52M |
| December 31, 2020 | 48.94M |
| December 31, 2019 | 30.71M |
| Date | Value |
|---|---|
| December 31, 2018 | 14.51M |
| December 31, 2017 | 12.39M |
| December 31, 2016 | 12.38M |
| December 31, 2015 | 9.333M |
| December 31, 2014 | 3.846M |
| December 31, 2013 | 3.176M |
| December 31, 2012 | 4.752M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Natera, Inc. | 624.11M |
| Caris Life Sciences, Inc. | 101.58M |
| Myriad Genetics, Inc. | 106.80M |
| BioRestorative Therapies, Inc. | 10.09M |
| Exagen, Inc. | 6.254M |